Discontinuation report TEVA-RISEDRONATE

Last updated on 2021-02-12 History
Report ID 133905
Drug Identification Number 02413809
Brand name TEVA-RISEDRONATE
Common or Proper name RISEDRONATE 150MG TABLET
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) RISEDRONATE SODIUM
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size PP 3
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-02-05
Remaining supply date 2021-02-05
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Item is disc
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-02-12 French Compare
v1 2021-02-12 English Compare